Cost-effectiveness of lung volume reduction surgery

Proceedings of the American Thoracic Society

Volumn 5, Issue 4, 2008, Pages 406-411

  Ramsey, Scott D ^a,b   Sullivan, Sean D ^c   Kaplan, Robert M ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trial; Cost effectiveness; Emphysema; Lung volume reduction surgery; Quality adjusted life years

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CORONARY ARTERY BYPASS SURGERY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FUNDING; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEART TRANSPLANTATION; HUMAN; LUNG EMPHYSEMA; LUNG RESECTION; LUNG TRANSPLANTATION; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REIMBURSEMENT; REVIEW;

COST-BENEFIT ANALYSIS; HUMANS; MULTICENTER STUDIES AS TOPIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PNEUMONECTOMY; PULMONARY EMPHYSEMA; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 43449090432     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200707-095ET     Document Type: Review

References (41)

1. Flaherty KR, Kazerooni EA, Curtis JL, Iannettoni M, Lange L, Schork MA, Martinez FJ. Short-term and long-term outcomes after bilateral lung volume reduction surgery: prediction by quantitative CT. Chest 2001;119:1337-1346.
2. Geddes D, Davies M, Koyama H, Hansell D, Pastorino U, Pepper J, Agent P, Cullinan P, MacNeill SJ, Goldstraw P. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med 2000;343:239-245.
3. Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorcsan J 3rd, Ferson PF, Holbert JM, Brown ML, Landreneau RJ. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996;334:1095-1099.
4. Gelb AF, McKenna RJ Jr, Brenner M, Schein MJ, Zamel N, Fischel R. Lung function 4 years after lung volume reduction surgery for emphysema. Chest 1999;116:1608-1615.
5. Pompeo E, Marino M, Nofroni I, Matteucci G, Mineo TC. Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. Ann Thorac Surg 2000;70:948-953. [Discussion, 954.]
6. Agency for Health Care Policy and Research. Lung volume reduction surgery for end-stage chronic obstructive pulmonary disease. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 1996. Publication No. 96-0062.
7. The National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. Chest 1999;116:1750-1761.
8. Gentry C. Second opinion: why Medicare covers a new lung surgery for just a few patients. Wall Street Journal June 29, 1998:A1.
9. Kaplan RM, Atkins CJ, Timms R. Validity of a quality of well-being scale as an outcomemeasure in chronic obstructive pulmonary disease. J Chronic Dis 1984;37:85-95.
10. Kaplan RM, Anderson JP, Patterson TL, McCutchan JA, Weinrich JD, Heaton RK, Atkinson JH, Thal L, Chandler J, Grant I. Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 1995;57:138-147.
11. Kaplan RM, Hartwell SL, Wilson DK, Wallace JP. Effects of diet and exercise interventions on control and quality of life in non-insulin-dependent diabetes mellitus. J Gen Intern Med 1987;2:220-228.
12. Ganiats TG, Palinkas LA, Kaplan RM. Comparison of Quality of Well-Being scale and Functional Status Index in patients with atrial fibrillation. Med Care 1992;30:958-964.
13. Kaplan RM. Quality of life assessment for cost/utility studies in cancer. Cancer Treat Rev 1993;19(Suppl A):85-96.
14. Kaplan RM. Decisions about prostate cancer screening in managed care. Curr Opin Oncol 1997;9:480-486.
15. Cooper JD, Trulock EP, Triantafillou AN, Patterson GA, Pohl MS, Deloney PA, Sundaresan RS, Roper CL. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995;109:106-116. [Discussion, 116]
16. Huizenga HF, Ramsey SD, Albert RK. Estimated growth of lung volume reduction surgery among Medicare enrollees: 1994 to 1996. Chest 1998;114:1583-1587.
17. Holohan TV, Handelsman H. Lung-volume reduction surgery for end-stage chronic obstructive pulmonary disease. Health Technol Assess (Rockv) 1996;:1-30.
18. Snider GL. Health-care technology assessment of surgical procedures: the case of reduction pneumoplasty for emphysema. Am J Respir Crit Care Med 1996;153:1208-1213.
19. Make BJ, Fein AM. Is volume reduction surgery appropriate in the treatment of emphysema? No. Am J Respir Crit Care Med 1996;153:1205-1207.
20. Utz JP, Hubmayr RD, Deschamps C. Lung volume reduction surgery for emphysema: out on a limb without a NETT. Mayo Clin Proc 1998;73:552-566.
21. Gold MR, Siegal JE, Russel LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
22. Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005;8:521-533.
23. Neumann PJ. Why don't Americans use cost-effectiveness analysis? Am J Manag Care 2004;10:308-312.
24. Kaplan RM, Anderson JP. The General Health Policy Model: an integrated approach. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1996. pp. 309-322.
25. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease.Ann Intern Med 1995;122:823-832.
26. Briggs AH, Goeree R, Blackhouse G, O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 2002;22:290-308.
27. Griffin S, Claxton K, Hawkins N, Sculpher M. Probabilistic analysis and computationally expensive models: necessary and required? Value Health 2006;9:244-252.
28. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996;15:1447-1458.
29. Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 2002;23:377-401.
30. National Emphysema Treatment Trial Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003;348:2092-2102.
31. Ramsey SD, Sullivan SD, Shroyer AL, Wood DE. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest 2007;131:823-832.
32. Miller JD, Malthaner RA, Goldsmith CH, Goeree R, Higgins D, Cox PG, Tan L, Road JD. A randomized clinical trial of lung volume reduction surgery versus best medical care for patients with advanced emphysema: a two-year study from Canada. Ann Thorac Surg 2006;81:314-320. [Discussion, 320-311.]
33. Drazen JM. Surgery for emphysema: not for everyone. N Engl J Med 2001;345:1126-1127.
34. Fein AM. Lung volume reduction surgery: answering the crucial questions. Chest 1998;113(Suppl):277S-282S.
35. Grady D. Medicare to pay for major lung operation. New York Times August 21, 2003;A22.
36. Centers for Medicare and Medicaid Services. Facilities eligible for reimbursement for lung volume reduction surgery [Internet] [accessed December 7, 2006]. U.S. Department of Health and Human Services. Available from: http://www.cms.hhs.gov/MedicareApprovedFacilitie/LVRS/list.asp? filterType5none&filterByDID50&sortByDID51&sortOrder5ascending& intNumPerPage510
37. Joint Commission on Accreditation of Healthcare Organizations. Lung volume reduction surgery certification requirements, 6/19/06 [Internet] [accessed December 7, 2006]. Available from: http://www.jointcommission. org/NR/rdonlyres/12EFD2D8-6FC9-498C-9AD8-944D8794CF45/0/LVRS_final_addendum.pdf
38. Centers for Medicare and Medicaid Services. Medicare national coverage determinations - lung volume reduction surgery: Pub 100-03, transmittal 44. [Internet] 2005 December 2 [cited 2007 December 4]. Available from: www.cms.hhs.gov/transmittals/downloads/R44NCD.pdf
39. Cigna Healthcare Coverage Position. Lung volume reduction surgery [Internet] [accessed December 7, 2006]. Coverage position number: 0218. Effective date: November 15, 2006. Available from: http://www.cigna.com/health/ provider/medical/procedural/coverage_positions/medical/ mm_0218_coveragepositioncriteria_lung_volume_reduction_surgery.pdf
40. The Regence Group. Medical policy on lung volume reduction surgery [Internet] [accessed December 4, 2007]. Available from: http://regence.com/ trgmedpol/surgery/sur31.html
41. Wagner JL, Alberts SR, Sloan JA, Cha S, Killian J, O'Connell MJ, Van Grevenhof P, Lindman J, Chute CG. Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst 1999;91:847-853.